Literature DB >> 26737909

Phenotypic characterisation of Crohn's disease severity.

Katherine E Niehaus, Holm H Uhlig, David A Clifton.   

Abstract

Crohn's disease (CD) is a highly heterogeneous disease, with great variation in patient severity. Using supervised machine learning techniques to predict severity from common laboratory and clinical measurements, we found that high levels of C-reactive protein and low levels of lymphocytes and albumin are important predictive factors. Building upon this knowledge, we used extreme value theory to create a probabilistic model that combines information about behaviour in the extremes of these lab measurements to produce a single risk score over time. We then clustered these patient risk scores to identify several common clinical trajectories for CD patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26737909     DOI: 10.1109/EMBC.2015.7320009

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Machine learning for subtype definition and risk prediction in heart failure, acute coronary syndromes and atrial fibrillation: systematic review of validity and clinical utility.

Authors:  Amitava Banerjee; Suliang Chen; Ghazaleh Fatemifar; Mohamad Zeina; R Thomas Lumbers; Johanna Mielke; Simrat Gill; Dipak Kotecha; Daniel F Freitag; Spiros Denaxas; Harry Hemingway
Journal:  BMC Med       Date:  2021-04-06       Impact factor: 11.150

2.  A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation.

Authors:  Imogen S Stafford; Mark M Gosink; Enrico Mossotto; Sarah Ennis; Manfred Hauben
Journal:  Inflamm Bowel Dis       Date:  2022-10-03       Impact factor: 7.290

Review 3.  A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases.

Authors:  I S Stafford; M Kellermann; E Mossotto; R M Beattie; B D MacArthur; S Ennis
Journal:  NPJ Digit Med       Date:  2020-03-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.